Bioject Medical Technologies In (BJCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,281 | -3,080 | -1,410 | -140 | 1,040 |
| Depreciation Amortization | 142 | 730 | 540 | 360 | 180 |
| Accounts receivable | -362 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 9 | 0 | 0 | 0 | 0 |
| Other Working Capital | -167 | 360 | 600 | 520 | 260 |
| Other Operating Activity | 638 | 850 | 80 | -170 | -3,430 |
| Operating Cash Flow | $-1,022 | $-1,140 | $-190 | $570 | $-1,950 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -90 | -80 | -70 | -7 |
| Net Acquisitions | N/A | 0 | -330 | -330 | -330 |
| Other Investing Activity | -13 | -400 | -30 | -30 | -13 |
| Investing Cash Flow | $-22 | $-490 | $-440 | $-430 | $-350 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 784 | 0 | 0 | 0 | 0 |
| Other Financing Activity | 0 | 7,250 | 2,500 | 2,400 | 2,400 |
| Financing Cash Flow | $784 | $7,250 | $2,500 | $2,400 | $2,400 |
| Beginning Cash Position | 6,884 | 1,270 | 1,270 | 1,270 | 1,270 |
| End Cash Position | 6,623 | 6,880 | 3,140 | 3,810 | 1,360 |
| Net Cash Flow | $-261 | $5,600 | $1,870 | $2,540 | $90 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,022 | -1,140 | -190 | 570 | -1,950 |
| Capital Expenditure | -10 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -1,032 | -1,140 | -190 | 570 | -1,950 |